Brian M Culley insider trades
Open-market stock purchases and sales by Brian M Culley, President and CEO at Lineage Cell Therapeutics, Inc, from SEC Form 4 filings since Feb 2, 2010.
Track record: 50% of 6 scored buys are up 5% or more since purchase, averaging +11%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 12, 2026 | LCTX Lineage Cell Therapeutics, Inc | Bought | $24.4K |
| Mar 5, 2026 | LCTX Lineage Cell Therapeutics, Inc | Bought (not open market) | — |
| Feb 11, 2026 | LCTX Lineage Cell Therapeutics, Inc | Sold (not open market) | $23.2K |
| Feb 11, 2026 | LCTX Lineage Cell Therapeutics, Inc | Bought (not open market) | — |
| Dec 19, 2025 | LCTX Lineage Cell Therapeutics, Inc | Bought (not open market) | — |
| Dec 19, 2025 | LCTX Lineage Cell Therapeutics, Inc | Sold (not open market) | $561 |
Companies traded
- LCTX Lineage Cell Therapeutics, Inc: 6 buys, 1 sale, last Mar 12, 2026
- BTX Biotime Inc: other filings, last Jan 1, 2019
- ATMS Artemis Therapeutics, Inc: 2 buys, last Mar 15, 2018
- MSTX Mast Therapeutics, Inc: other filings, last Jan 20, 2017
- ANX Adventrx Pharmaceuticals Inc: 3 buys, last Jan 2, 2013
- [ANX] Adventrx Pharmaceuticals Inc: 1 sale, last Jun 2, 2011